SKIP TO CONTENT
30+/SKIN
← REVIEWSRECORD R-10METHOD DESK REVIEWBRAND REPORT COREAGE RX →UPDATED 2026-10-05
PRESCRIPTION-GATED COSMETIC / BARRIER & FIRMNESS

CoreAge Rx / Bounce Back

COPPER PEPTIDE — CURRENT PAGE LISTS 2%

Bounce Back is CoreAge’s copper-peptide cream for the appearance of firmness and recovery. The current page lists 2%, replacing the 0.2% figure previously recorded here; that change does not prove a stronger clinical effect.

VERDICT — CONDITIONALPRESCRIPTION ONLYCOMPOUNDED — NOT FDA-APPROVED

Worth buying for a specific person with a specific problem. Read who.

PUBLIC-SOURCE ASSESSMENT
—/ 100

ASSESSED ON 0% OF THE MODEL. 6 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.

PRICE$64.99
BILLINGADVERTISED STARTING MONTHLY PRICE
FILL VOLUMECONFIRM DISPENSED QUANTITY
METHODDESK REVIEW
WHERE TO BUYCOREAGE RX
PRICE$64.99 / month advertisedClinician assessment before prescribing; confirm the selected order.START THE CONSULTATION

Read the complete order, prescription and renewal terms before starting.

01

The verdict

CONDITIONAL — DESK REVIEW

The most important update is the label claim. CoreAge’s current page explicitly describes copper peptide at 2%. The old 0.2% record is no longer the right description of that page. Ask the prescriber or pharmacy to confirm the exact ingredient identity and concentration of the preparation supplied to you.

A larger percentage is not a stand-alone performance test. The vehicle, ingredient form, stability, use pattern and population can all affect a result. We no longer describe this cream as the best-dosed product in the register or extrapolate a trial at another concentration into a guarantee for this one.

WHAT IT GETS RIGHT
  • The current product page names its intended use and headline ingredients.
  • The order requires clinical review before a prescription is dispensed.
WHAT IT GETS WRONG
  • Public marketing does not establish patient-specific suitability or finished-product results.
  • Ask for the full ingredient list, exact quantity and any details not shown in the offer.
02

Every active, assessed

AS PUBLISHED
03

Scoring

0% OF THE MODEL ASSESSEDHOW WE TEST →

Open the review comparison tray →

Bounce Back: Read the current panel. 2% — Current copper-peptide claim. 0.2% — Superseded record on this site. NO INFERENCE — A larger percentage does not prove better results
The current provider page says 2%. This is a label comparison, not a potency or clinical-outcome scale.

What the product page actually establishes

The offer starts at $64.99 per month and presents the cream as a repair-and-firmness option with clinician review. Those facts describe the commercial route. They do not establish that a person needs prescription treatment for a loss of firmness or that the cream will reproduce an outcome reported for a different copper-peptide formulation.

For a useful comparison, ask whether the formulation name, concentration and amount are fixed or selected after assessment. Keep a photo of the actual label with the order confirmation. If a future refill differs, ask why instead of assuming the previous amount or instructions still apply.

A fair reading of ingredient evidence

Laboratory mechanisms can explain why an ingredient is being investigated. They cannot tell a reader how much firmer their skin will become after using a particular subscription cream. A credible finished-product claim would identify the tested formula, comparator, participants, duration and measured outcome.

Concentration alone also cannot answer whether a product will be comfortable on reactive skin. Bring the rest of your routine and any prior contact reactions to the assessment. Do not infer universal compatibility or incompatibility with every acid or vitamin C product from an ingredient nickname.

Questions for the formulation discussion

Ask for the full base, preservative system, intended application area and storage directions. If the tube lacks a clear use-by date or the appearance changes, contact the pharmacy. A sales page’s claim about skin recovery is not advice to put the preparation onto a wound, active rash or newly treated skin.

Use the comparison tray linked from this record to put this record beside the Likeness range or a different ingredient pathway. The tray shows reported facts and open questions; it does not calculate which treatment your skin should receive.

The order is not the treatment plan

Keep the chosen product, full payment and next renewal date together. A starting monthly price may describe a recurring plan or a monthly equivalent. Confirm the dispensing quantity, shipping, consultation charges and what is owed before repeating an order. A delivery estimate does not include every possible delay in clinical review or fulfillment.

CoreAge’s general policy distinguishes stopping a future subscription from refunding an order already approved and transmitted to a pharmacy. It describes possible non-refundable consultation fees and a separate 30-day cutoff. Read the terms attached to the selected skincare order and resolve any different checkout promise before paying.

How this record was prepared

We read public product and policy pages on October 5, 2026 and checked the ingredient context against the sources below. We did not order the cream, inspect a pharmacy batch, interview a treating clinician or test it on a patient panel. Product directions can change; the label and clinician’s instructions for the dispensed prescription take priority over a general review.

This is a public-source assessment. Unmeasured clinical results, texture and tolerance are not converted into a product score. Our featured-provider order is a separate publisher preference, described in the disclosure. It is not a clinical ranking of these formulas.

04

Who this is for

AND WHO IT IS NOT
CONSIDER IT IF
  • You want to discuss this particular formula with a clinician.
  • You can compare the full payment and follow-up arrangement before ordering.
DO NOT USE IT IF
  • You have not resolved relevant allergies, pregnancy plans or medical-history questions with the clinician.
  • You need an assessment of a new, changing or undiagnosed skin lesion.
WHERE TO BUYCOREAGE RX
PRICE$64.99 / month advertisedClinician assessment before prescribing; confirm the selected order.START THE CONSULTATION

Read the complete order, prescription and renewal terms before starting.

THIS IS NOT MEDICAL ADVICE

This is an editorial assessment of published information about aprescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.

05

Sources

3 RECORDS
  1. S-01CoreAge Rx — Bounce Back Public source checked October 5, 2026. Provider descriptions are not independent product testing.
  2. S-02CoreAge Rx — payment, subscription and refund policy Public source checked October 5, 2026. Provider descriptions are not independent product testing.
  3. S-03FDA — compounding questions and answers Medical or regulatory context checked October 5, 2026; not a study of the reviewed finished product.
THE DRAW · NO. 01

Win a year of
prescription skincare

One reader gets a 12 months CoreAge Rx derm plan — the compounded, physician-reviewed subscription we take apart in the register. Worth $780. Leave an address and you are entered.

PRIZE
12 MONTHS OF COREAGE RX
VALUE
$780 — $64.99/MO × 12
ENTRY
ONE EMAIL ADDRESS

VALUE IS THE PUBLISHED $64.99/MONTH SUBSCRIPTION PRICE OVER TWELVE MONTHS, AS RECORDED IN R-10. NO PURCHASE NECESSARY. WE REVIEW COREAGE RX — WE DO NOT SELL IT.

DEPTH 000%
THE DRAW · ONE READER

Win a year of
prescription skincare

One reader gets a 12 months CoreAge Rx derm subscription — compounded, physician-reviewed, delivered. See the product records in our review register.

VALUE$780
TERM12 MONTHS$64.99/MO × 12

VALUE IS THE PUBLISHED $64.99/MONTH SUBSCRIPTION PRICE OVER TWELVE MONTHS, AS RECORDED IN R-10. NO PURCHASE NECESSARY. WE REVIEW COREAGE RX — WE DO NOT SELL IT.